Mitochondria in heart failure

Cardiovascular Research

Volumn 88, Issue 1, 2010, Pages 40-50

  Rosca, Mariana G ^a,b   Hoppel, Charles L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heart failure; Mitochondria; Oxidative phsophorylation; Respirasomes; Reversible phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; FATTY ACID; METOPROLOL; PROTEASOME; PROTEIN; REACTIVE OXYGEN METABOLITE; RESPIRASOME; UNCLASSIFIED DRUG;

ALLOSTERISM; BIOGENESIS; CELL FUNCTION; CELL PROLIFERATION; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG EFFICACY; ELECTRON TRANSPORT; ENERGY TRANSFER; HEART; HEART CONTRACTION; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; INTERFIBRILLAR MITOCHONDRIA; LIPID PEROXIDATION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MUSCLE FIBRIL; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; SUBSARCOLEMMA MITOCHONDRIA; TISSUE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ENERGY METABOLISM; HEART FAILURE; HUMANS; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 77956586695     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq240     Document Type: Review

References (162)

1. McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005;365:1877-1889.
2. Neubauer S. The failing heart\an engine out of fuel. NEJM 2007;356:1140-1151.
3. Dayer M, Cowie MR. Heart failure: diagnosis and healthcare burden. Clin Med 2004; 4:13-18.
4. Ashrafian H, Frenneaux MP. Metabolic modulation in heart failure: the coming of age. Cardiovasc Drug Ther 2007;21:5-7.
5. Sanbe A, Tanonaka K, Kobayasi R, Takeo S. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol 1995;27: 2209-2222.
6. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated car-diomyopathy. Circulation 1997;96:2190-2196.
7. Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, Kostler H et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002;40:1267-1274.
8. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005;85:1093-1129.
9. Schagger H, Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J 2000;19:1777-1783.
10. Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphoryl-ation. Cardiovasc Res 2008;80:30-39.
11. D'Aurelio M, Gajewski CD, Lenaz G, Manfredi G. Respiratory chain supercomplexes set the threshold for respiration defects in human mtDNA mutant cybrids. Hum Mol Genet 2006;15:2157-2169.
12. Boekema EJ, Braun HP. Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Biol Chem 2007;282:1-4.
13. Hoppel CL, Tandler B, Fujioka H, Riva A. Dynamic organization of mitochondria in human heart and in myocardial disease. Int J Biochem Cell Biol 2009;41:1949-1956.
14. Riva A, Tandler B, Loffredo F, Vazquez E, Hoppel C. Structural differences in two biochemically defined populations of cardiac mitochondria. Am J Physiol 2005;289: H868-H872.
15. Coleman R, Silbermann M, Gershon D, Reznick AZ. Giant mitochondria in the myocardium of aging and endurance-trained mice. Gerontol 1987;33:34-39.
16. Zak R, Rabinowitz M, Rajamanickam C, Merten S, Kwiatkowska-Patzer B. Mitochondrial proliferation in cardiac hypertrophy. Basic Res Cardiol 1980;75:171-178.
17. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL et al. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 1999;104:469-481.
18. Baandrup U, Florio RA, Roters F, Olsen EG. Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. A semiquanti-tative study in 48 patients. Circulation 1981;63:1289-1298.
19. Sharov VG, Goussev A, Lesch M, Goldstein S, Sabbah HN. Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1998;30: 1757-1762.
20. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP et al. Transcrip-tional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev 2008;22:1948-1961.
21. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochon-drial biogenesis. J Clin Invest 2000;106:847-856.
22. Stuewe SR, Gwirtz PA, Agarwal N, Mallet RT. Exercise training enhances glycolytic and oxidative enzymes in canine ventricular myocardium. J Mol Cell Cardiol 2000;32: 903-913.
23. Kayar SR, Conley KE, Claassen H, Hoppeler H. Capillarity and mitochondrial distribution in rat myocardium following exercise training. J Exp Biol 1986;120:189-199.
24. Kemi OJ, Hoydal MA, Haram PM, Garnier A, Fortin D, Ventura-Clapier R et al. Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan. Cardiovasc Res 2007;76:91-99.
25. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Fujii N, Miyazaki H et al. Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res 2003;26:829-837.
26. Nishio ML, Ornatsky OI, Craig EE, Hood DA. Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats. Can J Physiol Pharmacol 1995;73:630-637.
27. Wiesner RJ, Aschenbrenner V, Ruegg JC, Zak R. Coordination of nuclear and mito-chondrial gene expression during the development of cardiac hypertrophy in rats. Am J Physiol 1994;267:C229-C235.
28. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003;551:491-501.
29. Sun CK, Chang LT, Sheu JJ, Wang CY, Youssef AA, Wu CJ et al. Losartan preserves integrity of cardiac gap junctions and PGC-1 alpha gene expression and prevents cellular apoptosis in remote area of left ventricular myocardium following acute myo-cardial infarction. Int Heart J 2007;48:533-546.
30. Watson PA, Reusch JE, McCune SA, Leinwand LA, Luckey SW, Konhilas JP et al. Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol 2007;293:H246-H-259.
31. Jullig M, Hickey AJ, Chai CC, Skea GL, Middleditch MJ, Costa S et al. Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 2008;8:2556-2572.
32. Sebastiani M, Giordano C, Nediani C, Travaglini C, Borchi E, Zani M et al. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardio-myopathies. J Am Coll Cardiol 2007;50:1362-1369.
33. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997;16:226-234.
34. Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27: 181-186.
35. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL et al. Dilated cardiomyo-pathy and neonatal lethality in mutant mice lacking manganese superoxide dismu-tase. Nat Genet 1995;11:376-381.
36. Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci USA 2004;101:3136-3141.
37. Wang S, Fu C, Wang H, Shi Y, Xu X, Chen J et al. Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. Clin Chem Lab Med 2007;45:962-967.
38. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 1977;252: 8731-8739.
39. Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 1999;372:399-407.
40. Hoppel CL, Tandler B, Parland W, Turkaly JS, Albers LD. Hamster cardiomyopathy. A defect in oxidative phosphorylation in the cardiac interfibrillar mitochondria. J Biol Chem 1982;257:1540-1548.
41. Weinstein ES, Benson DW, Fry DE. Subpopulations of human heart mitochondria. J Surg Res 1986;40:495-498.
42. Palmer JW, Tandler B, Hoppel CL. Biochemical differences between subsarcolemmal and interfibrillar mitochondria from rat cardiac muscle: effects of procedural manipulations. Arch Biochem Biophys 1985;236:691-702.
43. Palmer JW, Tandler B, Hoppel CL. Heterogeneous response of subsarcolemmal heart mitochondria to calcium. Am J Physiol 1986;250:H741-H748.
44. Duan J, Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Pharmacol 1989;67:704-709.
45. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, Hoppel CL. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolem-mal mitochondria. Am J Physiol 1997;273:H1544-H1554.
46. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 2004; 279:47961-47967.
47. Hofer T, Servais S, Seo AY, Marzetti E, Hiona A, Upadhyay SJ et al. Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: effects of aging and lifelong calorie restriction. Mech Ageing Dev 2009;130: 297-307.
48. Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ et al. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 2001;385:117-128.
49. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 2005;19:419-421.
50. Dabkowski ER, Williamson CL, Bukowski VC, Chapman RS, Leonard SS, Peer CJ et al. Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochon-drial subpopulations. Am J Physiol 2009;296:H359-H369.
51. Williamson CL, Dabkowski ER, Baseler WA, Croston TL, Alway SE, Hollander JM. Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcel-lular spatial location. Am J Physiol 2009;298:H633-H642.
52. Heather LC, Carr CA, Stuckey DJ, Pope S, Morten KJ, Carter EE et al. Critical role of complex III in the early metabolic changes following myocardial infarction. Cardiovasc Res 2010;85:127-136.
53. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 2007;48:1559-1570.
54. Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res 2004; 95:568-578.
55. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115:500-508.
56. Young ME. The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol 2006;290:H1-H16.
57. Durgan DJ, Trexler NA, Egbejimi O, McElfresh TA, Suk HY, Petterson LE et al. The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acids. J Biol Chem 2006;281:24254-24269.
58. Van Bilsen M, Smeets PJ, Gilde AJ, Van Der Vusse GJ. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 2004;61:218-226.
59. Sochor H, Schelbert HR, Schwaiger M, Henze E, Phelps ME. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med 1986;12:S66-S69.
60. Davila-Roman VG, Vedala G, Herrero P, De las Fuentes L, Rogers JG, Kelly DP et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardio-myopathy. J Am Coll Cardiol 2002;40:271-277.
61. De Las Fuentes L, Herrero P, Peterson LR, Kelly DP, Gropler RJ, Davila-Roman VG. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 2003;41:83-87.
62. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 1994;267:H742-H750.
63. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998;83:969-979.
64. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 1994;26:1371-1375.
65. Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol 2007;293: H3270-H3278.
66. Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR et al. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 2002;106:606-612.
67. Kantor PF, Robertson MA, Coe JY, Lopaschuk GD. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol 1999;33:1724-1734.
68. Chandler MP, Kerner J, Huang H, Vazquez E, Reszko A, Martini WZ et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol 2004;287:H1538-H1543.
69. Razeghi P, Young ME, Ying J, Depre C, Uray IP, Kolesar J et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 2002;97:203-209.
70. Schupp M, Kintscher U, Fielitz J, Thomas J, Pregla R, Hetzer R et al. Cardiac PPAR-alpha expression in patients with dilated cardiomyopathy. Eur J Heart Fail 2006;8: 290-294.
71. Morgan EE, Chandler MP, Young ME, McElfresh TA, Kung TA, Rennison JH et al. Dissociation between gene and protein expression of metabolic enzymes in a rodent model of heart failure. Eur J Heart Fail 2006;8:687-693.
72. Bristow MR. beta-adrenergic receptor blockade in chronic heart failure. Circulation 2000;101:558-569.
73. Sharma V, Dhillon P, Wambolt R, Parsons H, Brownsey R, Allard MF et al. Metopro-lol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am J Physiol 2008;294:H1609-H1620.
74. Sharma V, Abraham T, So A, Allard MF, McNeill JH. Functional effects of protein kinases and peroxynitrite on cardiac carnitine palmitoyltransferase-1 in isolated mitochondria. Mol Cell Biochem 2010;337:223-237.
75. Mitchell P. Possible molecular mechanisms of the protonmotive function of cyto-chrome systems. J Theor Biol 1976;62:327-367.
76. Chance B, Williams GR. A method for the localization of sites for oxidative phos-phorylation. Nature 1955;176:250-254.
77. Wittig I, Carrozzo R, Santorelli FM, Schagger H. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation. Biochim Biophys Acta 2006;1757: 1066-1072.
78. Acin-Perez R, Fernandez-Silva P, Peleato ML, Perez-Martos A, Enriquez JA. Respiratory active mitochondrial supercomplexes. Mol Cell 2008;32:529-539.
79. Schafer E, Dencher NA, Vonck J, Parcej DN. Three-dimensional structure of the respiratory chain supercomplex I1III2IV1 from bovine heart mitochondria. Biochemistry 2007;46:12579-12585.
80. Vonck J, Schafer E. Supramolecular organization of protein complexes in the mito-chondrial inner membrane. Biochim Biophys Acta 2009;1793:117-124.
81. Fry M, Green DE. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem Biophys Res Commun 1980;93:1238-1246.
82. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1992;1113: 71-133.
83. Hoch FL. Cardiolipins and mitochondrial proton-selective leakage. J Bioenerg Bio-membr 1998;30:511-532.
84. Nalecz KA, Bolli R, Wojtczak L, Azzi A. The monocarboxylate carrier from bovine heart mitochondria: partial purification and its substrate-transporting properties in a reconstituted system. Biochim Biophys Acta 1986;851:29-37.
85. Paradies G, Petrosillo G, Ruggiero FM. Cardiolipin-dependent decrease of cyto-chrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim Biophys Acta 1997;1319:5-8. (Pubitemid 27138371)
86. Zhang M, Mileykovskaya E, Dowhan W. Gluing the respiratory chain together. Car-diolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 2002;277:43553-43556.
87. Brandner K, Mick DU, Frazier AE, Taylor RD, Meisinger C, Rehling P. Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome. Mol Biol Cell 2005;16: 5202-5214.
88. Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML et al. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 2003;278:52873-52880.
89. McKenzie M, Lazarou M, Thorburn DR, Ryan MT. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients. J Mol Biol 2006;361: 462-469.
90. Scacco S, Vergari R, Scarpulla RC, Technikova-Dobrova Z, Sardanelli A, Lambo R et al. cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures. J Biol Chem 2000;275:17578-17582.
91. Pagliarini DJ, Dixon JE. Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem Sci 2006;31:26-34.
92. Zippin JH, Chen Y, Nahirney P, Kamenetsky M, Wuttke MS, Fischman DA et al. Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J 2003;17:82-84.
93. DiPilato LM, Cheng X, Zhang J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci USA 2004;101:16513-16518.
94. Acin-Perez R, Salazar E, Kamenetsky M, Buck J, Levin LR, Manfredi G. Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab 2009;9:265-276.
95. Schwoch G, Trinczek B, Bode C. Localization of catalytic and regulatory subunits of cyclic AMP-dependent protein kinases in mitochondria from various rat tissues. Biochem J 1990;270:181-188.
96. Technikova-Dobrova Z, Sardanelli AM, Papa S. Phosphorylation of mitochondrial proteins in bovine heart. Characterization of kinases and substrates. FEBS Lett 1993;322:51-55.
97. Technikova-Dobrova Z, Sardanelli AM, Stanca MR, Papa S. cAMP-dependent protein phosphorylation in mitochondria of bovine heart. FEBS Lett 1994;350:187-191.
98. Sardanelli AM, Technikova-Dobrova Z, Scacco SC, Speranza F, Papa S. Characterization of proteins phosphorylated by the cAMP-dependent protein kinase of bovine heart mitochondria. FEBS Lett 1995;377:470-474.
99. Papa S, Sardanelli AM, Cocco T, Speranza F, Scacco SC, Technikova-Dobrova Z. The nuclear-encoded 18 kDa (IP) AQDQ subunit of bovine heart complex I is phosphorylated by the mitochondrial cAMP-dependent protein kinase. FEBS Lett 1996;379:299-301.
100. Sardanelli AM, Technikova-Dobrova Z, Speranza F, Mazzocca A, Scacco S, Papa S. Topology of the mitochondrial cAMP-dependent protein kinase and its substrates. FEBS Lett 1996;396:276-278.
101. Chen Q, Lin RY, Rubin CS. Organelle-specific targeting of protein kinase AII (PKAII). Molecular and in situ characterization of murine A kinase anchor proteins that recruit regulatory subunits of PKAII to the cytoplasmic surface of mitochondria. J Biol Chem 1997;272:15247-15257.
102. Affaitati A, Cardone L, De Cristofaro T, Carlucci A, Ginsberg MD, Varrone S et al. Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria. J Biol Chem 2003;278:4286-4294.
103. Cardone L, De Cristofaro T, Affaitati A, Garbi C, Ginsberg MD, Saviano M et al. A-kinase anchor protein 84/121 are targeted to mitochondria and mitotic spindles by overlapping amino-terminal motifs. J Mol Biol 2002;320:663-675.
104. Signorile A, Sardanelli AM, Nuzzi R, Papa S. Serine (threonine) phosphatase(s) acting on cAMP-dependent phosphoproteins in mammalian mitochondria. FEBS Lett 2002; 512:91-94.
105. Pagliarini DJ, Wiley SE, Kimple ME, Dixon JR, Kelly P, Worby CA et al. Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. Mol Cell 2005;19:197-207.
106. Schulenberg B, Aggeler R, Beechem JM, Capaldi RA, Patton WF. Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J Biol Chem 2003;278:27251-27255.
107. Chen R, Fearnley IM, Peak-Chew SY, Walker JE. The phosphorylation of subunits of complex I from bovine heart mitochondria. J Biol Chem 2004;279:26036-26045.
108. Bender E, Kadenbach B. The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phosphorylation. FEBS Lett 2000;466:130-134.
109. Lee I, Bender E, Arnold S, Kadenbach B. New control of mitochondrial membrane potential and ROS formation\a hypothesis. Biol Chem 2001;382:1629-1636.
110. Lee I, Bender E, Kadenbach B. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol Cell Biochem 2002;234-235:63-70.
111. Ludwig B, Bender E, Arnold S, Huttemann M, Lee I, Kadenbach B. Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chembiochem 2001;2: 392-403.
112. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997;416: 15-18.
113. Lee I, Salomon AR, Ficarro S, Mathes I, Lottspeich F, Grossman LI et al. cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J Biol Chem 2005;280:6094-6100.
114. Samavati L, Lee I, Mathes I, Lottspeich F, Huttemann M. Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J Biol Chem 2008;283:21134-21144.
115. Fang JK, Prabu SK, Sepuri NB, Raza H, Anandatheerthavarada HK, Galati D et al. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion. FEBS Lett 2007;581:1302-1310.
116. Prabu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, Avadhani NG. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 2006; 281:2061-2070.
117. Acin-Perez R, Salazar E, Brosel S, Yang H, Schon EA, Manfredi G. Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cyto-chrome oxidase defects. EMBO Mol Med 2009;1:392-406.
118. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2 + responses. Science 1998;280:1763-1766.
119. Rizzuto R, Bastianutto C, Brini M, Murgia M, Pozzan T. Mitochondrial Ca2 + homeo-stasis in intact cells. J Cell Biol 1994;126:1183-1194.
120. Hajnoczky G, Robb-Gaspers LD, Seitz MB, Thomas AP. Decoding of cytosolic calcium oscillations in the mitochondria. Cell 1995;82:415-424.
121. Rohacs T, Nagy G, Spat A. Cytoplasmic Ca2 + signalling and reduction of mitochon-drial pyridine nucleotides in adrenal glomerulosa cells in response to K +, angioten-sin II and vasopressin. Biochem J 1997;322:785-792.
122. Maechler P, Kennedy ED, Pozzan T, Wollheim CB. Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic beta-cells. EMBO J 1997;16:3833-3841.
123. Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R. Regulation of mitochon-drial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc Natl Acad Sci USA 1999;96:13807-13812.
124. Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na + transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 2002;277:43377-43388.
125. Liu X, Godwin ML, Nowak G. Protein kinase C-alpha inhibits the repair of oxidative phosphorylation after S-(1,2-dichlorovinyl)-L-cysteine injury in renal cells. Am J Physiol Renal Physiol 2004;287:F64-F73.
126. Ogbi M, Chew CS, Pohl J, Stuchlik O, Ogbi S, Johnson JA. Cytochrome c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal cardiac myo-cytes: implications for cytochrome c oxidase activity. Biochem J 2004;382:923-932.
127. Sayen MR, Gustafsson AB, Sussman MA, Molkentin JD, Gottlieb RA. Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am J Physiol Cell Physiol 2003;284:C562-C570.
128. Rosca MG, Hoppel CL. New aspects of impaired mitochondrial function in heart failure. J Bioenerg Biomembr 2009;41:107-112.
129. Jarreta D, Orus J, Barrientos A, Miro O, Roig E, Heras M et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res 2000;45:860-865.
130. Puchowicz MA, Varnes ME, Cohen BH, Friedman NR, Kerr DS, Hoppel CL. Oxi-dative phosphorylation analysis: assessing the integrated functional activity of human skeletal muscle mitochondria\case studies. Mitochondrion 2004;4:377-385.
131. Faustin B, Rossignol R, Rocher C, Benard G, Malgat M, Letellier T. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 2004;279:20411-20421.
132. Rossignol R, Malgat M, Mazat JP, Letellier T. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem 1999;274:33426-33432.
133. Groen AK, Wanders RJ, Westerhoff HV, Van Der Meer R, Tager JM. Quantification of the contribution of various steps to the control of mitochondrial respiration. J Biol Chem 1982;257:2754-2757.
134. Gellerich FN, Bohnensack R, Kunz W. Control of mitochondrial respiration. The contribution of the adenine nucleotide translocator depends on the ATP-and ADP-consuming enzymes. Biochim Biophys Acta 1983;722:381-391.
135. Villani G, Attardi G. In vivo control of respiration by cytochrome c oxidase in human cells. Free Radic Biol Med 2000;29:202-210.
136. Kadenbach B, Huttemann M, Arnold S, Lee I, Bender E. Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic Biol Med 2000;29:211-221.
137. Sanbe A, Tanonaka K, Niwano Y, Takeo S. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coen-zyme Q10 treatment. J Pharmacol Exp Ther 1994;269:51-56.
138. Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN. Abnormal mitochon-drial respiration in failed human myocardium. J Mol Cell Cardiol 2000;32:2361-2367.
139. Sanbe A, Tanonaka K, Hanaoka Y, Katoh T, Takeo S. Regional energy metabolism of failing hearts following myocardial infarction. J Mol Cell Cardiol 1993;25:995-1013.
140. Gong G, Liu J, Liang P, Guo T, Hu Q, Ochiai K et al. Oxidative capacity in failing hearts. Am J Physiol 2003;285:H541-H548.
141. Sordahl LA, McCollum WB, Wood WG, Schwartz A. Mitochondria and sarcoplas-mic reticulum function in cardiac hypertrophy and failure. Am J Physiol 1973;224: 497-502.
142. Lindenmayer GE, Harigaya S, Bajusz E, Schwartz A. Oxidative phosphorylation and calcium transport of mitochondria isolated from cardiomyopathic hamster hearts. J Mol Cell Cardiol 1970;1:249-259.
143. Wrogemann K, Blanchaer MC, Jacobson BE. Oxidative phosphorylation in cardio-myopathic hamsters. Am J Physiol 1972;222:1453-1457.
144. Lindenmayer GE, Sordahl LA, Schwartz A. Reevaluation of oxidative phosphoryl-ation in cardiac mitochondria from normal animals and animals in heart failure. Circ Res 1968;23:439-450.
145. Potluri P, Yadava N, Scheffler IE. The role of the ESSS protein in the assembly of a functional and stable mammalian mitochondrial complex I (NADH-ubiquinone oxidoreductase). Eur J Biochem 2004;271:3265-3273.
146. Au HC, Seo BB, Matsuno-Yagi A, Yagi T, Scheffler IE. The NDUFA1 gene product (MWFE protein) is essential for activity of complex I in mammalian mitochondria. Proc Natl Acad Sci USA 1999;96:4354-4359.
147. Raha S, Myint AT, Johnstone L, Robinson BH. Control of oxygen free radical formation from mitochondrial complex I: roles for protein kinase A and pyruvate dehy-drogenase kinase. Free Radic Biol Med 2002;32:421-430.
148. Sazanov LA, Peak-Chew SY, Fearnley IM, Walker JE. Resolution of the membrane domain of bovine complex I into subcomplexes: implications for the structural organization of the enzyme. Biochemistry 2000;39:7229-7235.
149. Yamaguchi M, Belogrudov GI, Matsuno-Yagi A, Hatefi Y. The multiple nicotinamide nucleotide-binding subunits of bovine heart mitochondrial NADH:ubiquinone oxidoreductase (complex I). Eur J Biochem 2000;267:329-336.
150. Schilling B, Aggeler R, Schulenberg B, Murray J, Row RH, Capaldi RA et al. Mass spec-trometric identification of a novel phosphorylation site in subunit NDUFA10 of bovine mitochondrial complex I. FEBS Lett 2005;579:2485-2490.
151. Tomitsuka E, Kita K, Esumi H. Regulation of succinate-ubiquinone reductase and fumarate reductase activities in human complex II by phosphorylation of its flavopro-tein subunit. Proc Jpn Acad 2009;85:258-265.
152. Ficarro S, Chertihin O, Westbrook VA, White F, Jayes F, Kalab P et al. Phosphopro-teome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J Biol Chem 2003;278:11579-11589.
153. Reinders J, Wagner K, Zahedi RP, Stojanovski D, Eyrich B, Van Der Laan M et al. Profiling phosphoproteins of yeast mitochondria reveals a role of phosphorylation in assembly of the ATP synthase. Mol Cell Proteomics. 2007;6:1896-1906.
154. Lee I, Salomon AR, Yu K, Doan JW, Grossman LI, Huttemann M. New prospects for an old enzyme: mammalian cytochrome c is tyrosine-phosphorylated in vivo. Biochemistry 2006;45:9121-9128.
155. Yu H, Lee I, Salomon AR, Yu K, Huttemann M. Mammalian liver cytochrome c is tyrosine-48 phosphorylated in vivo, inhibiting mitochondrial respiration. Biochim Biophys Acta 2008;1777:1066-1071.
156. Helling S, Vogt S, Rhiel A, Ramzan R, Wen L, Marcus K et al. Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol Cell Proteomics 2008;7: 1714-1724.
157. Miyazaki T, Neff L, Tanaka S, Horne WC, Baron R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol 2003;160:709-718.
158. Demory ML, Boerner JL, Davidson R, Faust W, Miyake T, Lee I et al. Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J Biol Chem 2009;284:36592-36604.
159. Steenaart NA, Shore GC. Mitochondrial cytochrome c oxidase subunit IV is phos-phorylated by an endogenous kinase. FEBS Lett 1997;415:294-298.
160. Bykova NV, Egsgaard H, Moller IM. Identification of 14 new phospho-proteins involved in important plant mitochondrial processes. FEBS Lett 2003;540: 141-146.
161. Hojlund K, Wrzesinski K, Larsen PM, Fey SJ, Roepstorff P, Handberg A et al. Pro-teome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 2003;278:10436-10442.
162. Feng J, Lucchinetti E, Enkavi G, Wang Y, Gehrig P, Roschitzki B et al. Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria. Am J Physiol Cell Physiol 2010;298: C740-C748.